Fig. 1From: The potential of deferasirox as a novel therapeutic modality in gastric cancerInhibitory effect of deferasirox on the growth of gastric cancer cell lines. a Cell viability was measured by the MTT assay. AGS, MKN-28, SNU-484, and SNU-638 cells were incubated with 0, 1, 10, 50, and 100 μM of deferasirox at 37 °C for 24, 48, or 72 h. Deferasirox treatment resulted in dose-dependent and time-dependent growth inhibition in all four gastric cancer cell lines. b AGS cells were cultured with 10 and 20 μM of deferasirox either alone or in the presence of FeSO4 (100 μM) for 48 h. The inhibitory effect of deferasirox was reversed by FeSO4 supplementBack to article page